NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 4M, up 29.9% from the year before. The highest annual figure on record is 4M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4M | +29.9% |
| FY2024 | Dec 31, 2024 | 3M | +0.1% |
| FY2023 | Dec 31, 2023 | 3M | +500.5% |
| FY2022 | Dec 31, 2022 | 0M | +65.4% |
| FY2021 | Dec 31, 2021 | 0M | +71.0% |
| FY2020 | Dec 31, 2020 | 0M | +1.8% |
| FY2019 | Dec 31, 2019 | 0M | +9.6% |
| FY2018 | Dec 31, 2018 | 0M | – |
See a number that looks wrong?